Detalles de la búsqueda
1.
Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study).
Hepatology
; 78(1): 272-283, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815354
2.
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study.
Clin Gastroenterol Hepatol
; 21(3): 713-722.e3, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35436624
3.
Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community-based cohort.
Hepatology
; 76(5): 1438-1451, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35474232
4.
The NAFLD burden on mortality and morbidities in general population: A community-based longitudinal study (NASH-CO study).
Liver Int
; 43(10): 2096-2106, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37452492
5.
The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population-based follow-up study (NASHCO).
Liver Int
; 42(3): 595-606, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35066992
6.
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts.
Liver Int
; 42(6): 1386-1400, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35025128
7.
Immunosuppression in patients with grade 3 acute-on-chronic liver failure at transplantation: A practice analysis study.
Clin Transplant
; 36(4): e14580, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34974638
8.
Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study).
Dig Dis Sci
; 67(6): 2584-2593, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34031802
9.
Elevated Fatty Liver Index as a Risk Factor for All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis C Virus-Coinfected Patients (ANRS CO13 HEPAVIH Cohort Study).
Hepatology
; 71(4): 1182-1197, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31466125
10.
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis.
Liver Int
; 41(6): 1227-1242, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33590598
11.
Liver transplantation for critically ill cirrhotic patients: Stratifying utility based on pretransplant factors.
Am J Transplant
; 20(9): 2437-2448, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32185866
12.
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Gastroenterology
; 156(4): 997-1009.e5, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30768988
13.
Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD.
Hepatology
; 79(5): E130-E131, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38252803
14.
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study.
Liver Int
; 40(5): 1042-1051, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31765046
15.
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
Clin Gastroenterol Hepatol
; 17(8): 1625-1633.e1, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30476585
16.
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
Gastroenterology
; 155(5): 1436-1450.e6, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30031138
17.
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Gastroenterology
; 155(2): 431-442.e10, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29729258
18.
The accuracy of baseline viral load for predicting the efficacy of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1a infection: An integrated analysis.
J Viral Hepat
; 26(3): 329-336, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30412325
19.
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort.
J Viral Hepat
; 26(3): 384-396, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30380181